Taken together, our analysis strongly suggests that the collybistin p.R356Q variant is responsible for the mild intellectual disability observed in this family—due to disruption of collybistin PI3P binding, leading to a decrease in synaptic gephyrin and GABAA receptor clustering. Here, GPHN is linked to Intellectual disability.